To quantify the general effects of BRD9 bromodomain inhibition on AML cells, we averaged the results presented in Fig. 1A across all AML cell lines and compared these results with the effects on HEK293T cells (Fig. 1B). Here, BRD9 is linked to acute myeloid leukemia.